Browsing by Author "Burazor, Ivana (24767517700)"
Now showing 1 - 12 of 12
- Results Per Page
- Sort Options
- Some of the metrics are blocked by yourconsent settings
Publication A Global Perspective on Cardiovascular Risk Factors by Educational Level in CHD Patients: SURF CHD II(2024) ;Marzà-Florensa, Anna (57418164000) ;Vaartjes, Ilonca (16025833300) ;Graham, Ian (35373661800) ;Klipstein-Grobusch, Kerstin (7003935853) ;Grobbee, Diederick E. (57216110328) ;Joseph, Marina (59389853100) ;Costa, Yanina Castillo (24390399600) ;Enrique, Nicolás Esteybar (59389631800) ;Gabulova, Rahima (57312946500) ;Isaveva, Mahluga (59389272100) ;Alivev, Farid (59389744700) ;Rahimov, Uzeyir (15830066600) ;Imanov, Galib (35324512100) ;Ibrahimov, Firdovsi (14045359000) ;Naila, Zarbaliyeva (59389272200) ;Abasov, Rashad (59389510500) ;Dendale, Paul (7003942842) ;Jassen, Anre (59389510600) ;De Sutter, Johan (35452209100) ;Cuypers, Sofie (9740172300) ;Precoma, Dalton (15074334200) ;Ritt, Luiz (54998293200) ;Sturzeneker, Mario Claudio Soares (36970979300) ;Filho, Conrado Roberto Hoffmann (56712468300) ;Lira, Maria Teresa (34979872800) ;Varablik, Michal (59389744800) ;Tumova, Eva (57196100717) ;Ozana, Jaromir (57219245187) ;Bovin, Ann (25642549800) ;Viigimaa, Margus (57221665512) ;Tsioufis, Konstantinos (55355673900) ;Laina, Ageliki (56450915300) ;Achilles, Zacharoulis (59389510700) ;Toulgaridis, Fotios (57222575287) ;Sanidas, Elias (22941983300) ;Reiner, Zeljko (55411641000) ;Gulin, Marijana (24068539000) ;BejúiC, Antonijo (59389510800) ;Duplancic, Darko (8691046700) ;Šikic, Jozica (25951661600) ;Szabados, Eszter (6603735509) ;Tiksnadi, Badai Bhatara (57206787371) ;McEvoy, Bill (59389272300) ;Reynolds, Anne (23490021100) ;Moore, David (7404566224) ;Spelman, Declan (59389510900) ;Puri, Raman (9433943200) ;Nanda, Rashmi (57215087839) ;Desai, Nagaraj (7102028726) ;Dorairaj, Prabhakar (57207550534) ;Iyengar, S.S. (7202158141) ;Lakshmana, Sumitra (57201387130) ;Pandey, Ajay Kumar (59389974800) ;Pradhan, Akshyaya (57217994548) ;Mahajan, Kunal (57143972800) ;Faggiano, Pompilio (7005603164) ;Zarcone, P. (59389974900) ;Abrignani, Maurizio G. (6603958287) ;Daniyar, Makhanov (59389272500) ;Davletov, Kairat (6602803024) ;Toleubekov, Kuatbek (59389272600) ;Visternichan, Olga (57191264114) ;Mereke, Alibek (57205595662) ;Dushpanova, Anar (55255161200) ;Zholdin, Bekbolat (57195996055) ;Timirbayev, Zhanat (59389975000) ;Derbissalina, Gulmira (57205585158) ;Aldyngurov, Daulet K. (36536580200) ;Myssayev, Ayan (55866500800) ;Nurtazina, Alma (57218650549) ;Romanova, Zhanna (57201530164) ;Kalmakhanov, Sundetgali (56823572700) ;Mintale, Iveta (16302191200) ;Msalam, Omar (23474560000) ;Ehemmali, Emhemed (59389511000) ;Mohamed, Alami (59389390600) ;Mouine, Najat (36606502500) ;Amale, Tazi Mezalek (59389975100) ;Soufiani, Aida (35330816300) ;Agoumy, Zineb (58174265800) ;Bachri, Houda (57201655753) ;Massri, Imad (59389744900) ;Mitevska, Irena (56698414500) ;Haitjema, Saskia (56326976300) ;De Groot, Mark (7102642748) ;Abreu, Ana (7006264493) ;Mosterou, Svetlana (36605040900) ;Gaita, Dan (59022309200) ;Pogosova, Nana (57222564306) ;Ezhov, Marat V. (57218254057) ;Kinsara, Abdulhalim (35564130600) ;Burazor, Ivana (24767517700) ;Giga, Vojislav (55924460200) ;Bueno, Hector (57218323754) ;Dalmau, Regina (15748177200) ;García-Barrios, Ana (57222196554) ;Duque, Jose Antonio Alarcon (57224202428) ;Mendinueta, Joana Reparaz (59389390700) ;Kayikcioglu, Meral (57202353075) ;Tokgozoglu, Lale (7004724917) ;Aslanger, Emre (25722980300) ;Cabbar, Ayca Turer (57336780900) ;Kim, Samuel (57202748091) ;Self, Caleb (59389857800) ;Reynolds, Dolores (56640618900) ;Rose, Sabrina (59389155100)Singh, Pretti (59389155200)Background: Clinical guidelines recommend lifestyle modifications and medication use to control cardiovascular risk factors in coronary heart disease (CHD) patients. However, risk factor control remains challenging especially in patients with lower educational level. Objective: To assess inequalities by educational level in the secondary prevention of CHD in the Survey of Risk Factors in Coronary Heart Disease (SURF CHD II). Methods: SURF CHD II is a cross-sectional clinical audit on secondary prevention of CHD, conducted during routine clinical visits in 29 countries. The easy-to-perform design of the survey facilitates its implementation in settings with limited resources. We reported risk factor recording, attainment of guideline-defined risk factor targets, and treatment in CHD patients. Differences by educational level in target attainment and treatment were assessed with logistic regression stratified for high- (HIC), upper middle- (UMIC), and lower middle-income (LMIC) countries. Results: SURF CHD II included 13,884 patients from 2019 to 2022, of which 25.0% were female and 18.6% had achieved only primary school level. Risk factor recording ranged from 22.2% for waist circumference to 95.6% for smoking status, and target attainment from 15.9% for waist circumference to 78.7% for smoking. Most patients used cardioprotective medications and 50.5% attended cardiac rehabilitation. Patients with secondary or tertiary education were more likely to meet targets for smoking, LDL cholesterol and physical activity in HICs and LMICs; for physical activity and triglycerides in UMICs; but less likely to meet targets for blood pressure in HICs and LDL <1.4mmol/L in UMICs. Higher education was positively associated with medication use and cardiac rehabilitation participation. CONCLUSION: CHD patients generally have poor attainment of risk factor targets, but patients with a higher educational level are generally more likely to participate in cardiac rehabilitation, use medication, and meet targets. © 2024 The Author(s). - Some of the metrics are blocked by yourconsent settings
Publication A Global Perspective on Cardiovascular Risk Factors by Educational Level in CHD Patients: SURF CHD II(2024) ;Marzà-Florensa, Anna (57418164000) ;Vaartjes, Ilonca (16025833300) ;Graham, Ian (35373661800) ;Klipstein-Grobusch, Kerstin (7003935853) ;Grobbee, Diederick E. (57216110328) ;Joseph, Marina (59389853100) ;Costa, Yanina Castillo (24390399600) ;Enrique, Nicolás Esteybar (59389631800) ;Gabulova, Rahima (57312946500) ;Isaveva, Mahluga (59389272100) ;Alivev, Farid (59389744700) ;Rahimov, Uzeyir (15830066600) ;Imanov, Galib (35324512100) ;Ibrahimov, Firdovsi (14045359000) ;Naila, Zarbaliyeva (59389272200) ;Abasov, Rashad (59389510500) ;Dendale, Paul (7003942842) ;Jassen, Anre (59389510600) ;De Sutter, Johan (35452209100) ;Cuypers, Sofie (9740172300) ;Precoma, Dalton (15074334200) ;Ritt, Luiz (54998293200) ;Sturzeneker, Mario Claudio Soares (36970979300) ;Filho, Conrado Roberto Hoffmann (56712468300) ;Lira, Maria Teresa (34979872800) ;Varablik, Michal (59389744800) ;Tumova, Eva (57196100717) ;Ozana, Jaromir (57219245187) ;Bovin, Ann (25642549800) ;Viigimaa, Margus (57221665512) ;Tsioufis, Konstantinos (55355673900) ;Laina, Ageliki (56450915300) ;Achilles, Zacharoulis (59389510700) ;Toulgaridis, Fotios (57222575287) ;Sanidas, Elias (22941983300) ;Reiner, Zeljko (55411641000) ;Gulin, Marijana (24068539000) ;BejúiC, Antonijo (59389510800) ;Duplancic, Darko (8691046700) ;Šikic, Jozica (25951661600) ;Szabados, Eszter (6603735509) ;Tiksnadi, Badai Bhatara (57206787371) ;McEvoy, Bill (59389272300) ;Reynolds, Anne (23490021100) ;Moore, David (7404566224) ;Spelman, Declan (59389510900) ;Puri, Raman (9433943200) ;Nanda, Rashmi (57215087839) ;Desai, Nagaraj (7102028726) ;Dorairaj, Prabhakar (57207550534) ;Iyengar, S.S. (7202158141) ;Lakshmana, Sumitra (57201387130) ;Pandey, Ajay Kumar (59389974800) ;Pradhan, Akshyaya (57217994548) ;Mahajan, Kunal (57143972800) ;Faggiano, Pompilio (7005603164) ;Zarcone, P. (59389974900) ;Abrignani, Maurizio G. (6603958287) ;Daniyar, Makhanov (59389272500) ;Davletov, Kairat (6602803024) ;Toleubekov, Kuatbek (59389272600) ;Visternichan, Olga (57191264114) ;Mereke, Alibek (57205595662) ;Dushpanova, Anar (55255161200) ;Zholdin, Bekbolat (57195996055) ;Timirbayev, Zhanat (59389975000) ;Derbissalina, Gulmira (57205585158) ;Aldyngurov, Daulet K. (36536580200) ;Myssayev, Ayan (55866500800) ;Nurtazina, Alma (57218650549) ;Romanova, Zhanna (57201530164) ;Kalmakhanov, Sundetgali (56823572700) ;Mintale, Iveta (16302191200) ;Msalam, Omar (23474560000) ;Ehemmali, Emhemed (59389511000) ;Mohamed, Alami (59389390600) ;Mouine, Najat (36606502500) ;Amale, Tazi Mezalek (59389975100) ;Soufiani, Aida (35330816300) ;Agoumy, Zineb (58174265800) ;Bachri, Houda (57201655753) ;Massri, Imad (59389744900) ;Mitevska, Irena (56698414500) ;Haitjema, Saskia (56326976300) ;De Groot, Mark (7102642748) ;Abreu, Ana (7006264493) ;Mosterou, Svetlana (36605040900) ;Gaita, Dan (59022309200) ;Pogosova, Nana (57222564306) ;Ezhov, Marat V. (57218254057) ;Kinsara, Abdulhalim (35564130600) ;Burazor, Ivana (24767517700) ;Giga, Vojislav (55924460200) ;Bueno, Hector (57218323754) ;Dalmau, Regina (15748177200) ;García-Barrios, Ana (57222196554) ;Duque, Jose Antonio Alarcon (57224202428) ;Mendinueta, Joana Reparaz (59389390700) ;Kayikcioglu, Meral (57202353075) ;Tokgozoglu, Lale (7004724917) ;Aslanger, Emre (25722980300) ;Cabbar, Ayca Turer (57336780900) ;Kim, Samuel (57202748091) ;Self, Caleb (59389857800) ;Reynolds, Dolores (56640618900) ;Rose, Sabrina (59389155100)Singh, Pretti (59389155200)Background: Clinical guidelines recommend lifestyle modifications and medication use to control cardiovascular risk factors in coronary heart disease (CHD) patients. However, risk factor control remains challenging especially in patients with lower educational level. Objective: To assess inequalities by educational level in the secondary prevention of CHD in the Survey of Risk Factors in Coronary Heart Disease (SURF CHD II). Methods: SURF CHD II is a cross-sectional clinical audit on secondary prevention of CHD, conducted during routine clinical visits in 29 countries. The easy-to-perform design of the survey facilitates its implementation in settings with limited resources. We reported risk factor recording, attainment of guideline-defined risk factor targets, and treatment in CHD patients. Differences by educational level in target attainment and treatment were assessed with logistic regression stratified for high- (HIC), upper middle- (UMIC), and lower middle-income (LMIC) countries. Results: SURF CHD II included 13,884 patients from 2019 to 2022, of which 25.0% were female and 18.6% had achieved only primary school level. Risk factor recording ranged from 22.2% for waist circumference to 95.6% for smoking status, and target attainment from 15.9% for waist circumference to 78.7% for smoking. Most patients used cardioprotective medications and 50.5% attended cardiac rehabilitation. Patients with secondary or tertiary education were more likely to meet targets for smoking, LDL cholesterol and physical activity in HICs and LMICs; for physical activity and triglycerides in UMICs; but less likely to meet targets for blood pressure in HICs and LDL <1.4mmol/L in UMICs. Higher education was positively associated with medication use and cardiac rehabilitation participation. CONCLUSION: CHD patients generally have poor attainment of risk factor targets, but patients with a higher educational level are generally more likely to participate in cardiac rehabilitation, use medication, and meet targets. © 2024 The Author(s). - Some of the metrics are blocked by yourconsent settings
Publication Cardiac tamponade(2023) ;Adler, Yehuda (7005992564) ;Ristić, Arsen D. (7003835406) ;Imazio, Massimo (55787131200) ;Brucato, Antonio (7006007796) ;Pankuweit, Sabine (7003360984) ;Burazor, Ivana (24767517700) ;Seferović, Petar M. (6603594879)Oh, Jae K. (7402155034)Cardiac tamponade is a medical emergency caused by the progressive accumulation of pericardial fluid (effusion), blood, pus or air in the pericardium, compressing the heart chambers and leading to haemodynamic compromise, circulatory shock, cardiac arrest and death. Pericardial diseases of any aetiology as well as complications of interventional and surgical procedures or chest trauma can cause cardiac tamponade. Tamponade can be precipitated in patients with pericardial effusion by dehydration or exposure to certain medications, particularly vasodilators or intravenous diuretics. Key clinical findings in patients with cardiac tamponade are hypotension, increased jugular venous pressure and distant heart sounds (Beck triad). Dyspnoea can progress to orthopnoea (with no rales on lung auscultation) accompanied by weakness, fatigue, tachycardia and oliguria. In tamponade caused by acute pericarditis, the patient can experience fever and typical chest pain increasing on inspiration and radiating to the trapezius ridge. Generally, cardiac tamponade is a clinical diagnosis that can be confirmed using various imaging modalities, principally echocardiography. Cardiac tamponade is preferably resolved by echocardiography-guided pericardiocentesis. In patients who have recently undergone cardiac surgery and in those with neoplastic infiltration, effusive–constrictive pericarditis, or loculated effusions, fluoroscopic guidance can increase the feasibility and safety of the procedure. Surgical management is indicated in patients with aortic dissection, chest trauma, bleeding or purulent infection that cannot be controlled percutaneously. After pericardiocentesis or pericardiotomy, NSAIDs and colchicine can be considered to prevent recurrence and effusive–constrictive pericarditis. © 2023, Springer Nature Limited. - Some of the metrics are blocked by yourconsent settings
Publication Cardiopulmonary Exercise Testing and Cardiac Rehabilitation in Amyloidosis(2023) ;Costa, Ricardo Vivacqua Cardoso (7203063226) ;Serra, Salvador Manoel (7102074697)Burazor, Ivana (24767517700)Functional assessment through cardiopulmonary exercise testing plays an essential role in analyzing the patient’s condition with amyloidosis, particularly with heart failure. It is a method that, like the treadmill test, makes it possible to prescribe exercise intensity in a rehabilitation program and be a highly suitable method for identifying the patient’s prognosis. Life cardiac rehabilitation programs, conceived broadly, can contribute to the patient’s quality of life with kindness. In this chapter, we answer these questions. © The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerland AG 2023. - Some of the metrics are blocked by yourconsent settings
Publication Comparison of ketamine and ketofol for deep sedation and analgesia in children undergoing laser procedure(2017) ;Stevic, Marija (55804941500) ;Ristic, Nina (57194832760) ;Budic, Ivana (16548855200) ;Ladjevic, Nebojsa (16233432900) ;Trifunovic, Branislav (8269362700) ;Rakic, Ivan (57715378200) ;Majstorovic, Marko (23971198500) ;Burazor, Ivana (24767517700)Simic, Dusica (16679991000)The aim of our study was to research and evaluate cardiovascular and respiratory stability, clinical efficacy, and safety of two different anesthetic agents in pediatric patients who underwent Pulse dye (wavelength 595 nm, pulse duration 0–40 ms, power 0–40 J) and CO2 (wavelength 10,600 nm, intensity-fraxel mod with SX index 4 to 8, power 0–30 W) laser procedure. This prospective non-blinded study included 203 pediatric patients ASA I-II, aged between 1 month and 12 years who underwent short-term procedural sedation and analgesia for the laser procedure. After oral premedication with midazolam, 103 children were analgo-sedated with ketamine and fentanyl (K group) and 100 with ketofol and fentanyl (KT group). Vital signs, applied drug doses, pulse oximetry, and parental satisfaction questionnaire were used to compare these two groups. Statistical differences were tested using Student’s t test, Mann-Whitney U test, chi-square test, and Fisher’s exact test. Receiver operating characteristic (ROC) curve analysis was used to assess the cut-off value of the duration of anesthesia predicting apnea. Tachycardia was recorded in a significantly higher number of patients who received ketamine as the anesthetic agent (35.9 vs. 3% respectively). Hypertension was also significantly more frequent in patients who received ketamine in comparison with patients who received ketofol (25.2 vs. 3%). Laryngospasm was not observed in both examined groups. There was no statistically significant difference between groups in satisfaction of parents and doctors. Apnea and respiratory depression occurred significantly more frequent in ketofol than in ketamine group (12 vs. 0.97% and 13 vs. 0%). Based on ROC analysis for apnea, we found a significantly higher number of patients with apnea in the ketofol group when duration of anesthesia was longer than 17 min. Our study has shown that ketofol is more comfortable than ketamine in short-term laser procedures in children, causing less hemodynamic alteration with mild respiratory depression and less post-procedural adverse events. © 2017, Springer-Verlag London Ltd. - Some of the metrics are blocked by yourconsent settings
Publication Diagnosis and treatment of cardiac amyloidosis. A position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases(2021) ;Garcia-Pavia, Pablo (57197883068) ;Rapezzi, Claudio (7005883289) ;Adler, Yehuda (7005992564) ;Arad, Michael (7004305446) ;Basso, Cristina (7004539938) ;Brucato, Antonio (7006007796) ;Burazor, Ivana (24767517700) ;Caforio, Alida L.P. (7005166754) ;Damy, Thibaud (6506337417) ;Eriksson, Urs (7102875592) ;Fontana, Marianna (16306839900) ;Gillmore, Julian D. (7003539031) ;Gonzalez-Lopez, Esther (56453004900) ;Grogan, Martha (7004085182) ;Heymans, Stephane (6603326423) ;Imazio, Massimo (55787131200) ;Kindermann, Ingrid (6603127742) ;Kristen, Arnt V. (7801324099) ;Maurer, Mathew S. (35515053700) ;Merlini, Giampaolo (7006059649) ;Pantazis, Antonis (6508359030) ;Pankuweit, Sabine (7003360984) ;Rigopoulos, Angelos G. (6701402043)Linhart, Ales (7004149017)Cardiac amyloidosis is a serious and progressive infiltrative disease that is caused by the deposition of amyloid fibrils at the cardiac level. It can be due to rare genetic variants in the hereditary forms or as a consequence of acquired conditions. Thanks to advances in imaging techniques and the possibility of achieving a non-invasive diagnosis, we now know that cardiac amyloidosis is a more frequent disease than traditionally considered. In this position paper the Working Group on Myocardial and Pericardial Disease proposes an invasive and non-invasive definition of cardiac amyloidosis, addresses clinical scenarios and situations to suspect the condition and proposes a diagnostic algorithm to aid diagnosis. Furthermore, we also review how to monitor and treat cardiac amyloidosis, in an attempt to bridge the gap between the latest advances in the field and clinical practice. © European Society of Cardiology 2021 - Some of the metrics are blocked by yourconsent settings
Publication Diagnosis and treatment of cardiac amyloidosis: A position statement of the ESC Working Group on Myocardial and Pericardial Diseases(2021) ;Garcia-Pavia, Pablo (57197883068) ;Rapezzi, Claudio (7005883289) ;Adler, Yehuda (7005992564) ;Arad, Michael (7004305446) ;Basso, Cristina (7004539938) ;Brucato, Antonio (7006007796) ;Burazor, Ivana (24767517700) ;Caforio, Alida L. P (7005166754) ;Damy, Thibaud (6506337417) ;Eriksson, Urs (7102875592) ;Fontana, Marianna (16306839900) ;Gillmore, Julian D (7003539031) ;Gonzalez-Lopez, Esther (56453004900) ;Grogan, Martha (7004085182) ;Heymans, Stephane (6603326423) ;Imazio, Massimo (55787131200) ;Kindermann, Ingrid (6603127742) ;Kristen, Arnt V (7801324099) ;Maurer, Mathew S (35515053700) ;Merlini, Giampaolo (7006059649) ;Pantazis, Antonis (6508359030) ;Pankuweit, Sabine (7003360984) ;Rigopoulos, Angelos G (6701402043)Linhart, Ales (7004149017)Cardiac amyloidosis is a serious and progressive infiltrative disease that is caused by the deposition of amyloid fibrils at the cardiac level. It can be due to rare genetic variants in the hereditary forms or as a consequence of acquired conditions. Thanks to advances in imaging techniques and the possibility of achieving a non-invasive diagnosis, we now know that cardiac amyloidosis is a more frequent disease than traditionally considered. In this position paper the Working Group on Myocardial and Pericardial Disease proposes an invasive and non-invasive definition of cardiac amyloidosis, addresses clinical scenarios and situations to suspect the condition and proposes a diagnostic algorithm to aid diagnosis. Furthermore, we also review how to monitor and treat cardiac amyloidosis, in an attempt to bridge the gap between the latest advances in the field and clinical practice. © The Author(s), 2021. - Some of the metrics are blocked by yourconsent settings
Publication Metastatic cardiac tumors: From clinical presentation through diagnosis to treatment(2018) ;Burazor, Ivana (24767517700) ;Aviel-Ronen, Sarit (6602442666) ;Imazio, Massimo (55787131200) ;Goitein, Orly (6505772996) ;Perelman, Marina (57196546470) ;Shelestovich, Natalia (57196438363) ;Radovanovic, Ninoslav (57200860335) ;Kanjuh, Vladimir (57213201627) ;Barshack, Iris (7003939286)Adler, Yehuda (7005992564)Background: To evaluate the prevalence of metastatic tumors involving the myocardium and study their presentation in order to increase awareness to their existence. Methods: Pathological reports from Sheba Medical Center (Israel, January 1, 2010 through December 31, 2015) and medical records from The Institute for Cardiovascular Diseases of Vojvodina, Sremska Kamenica (Serbia, 23years period) were screened for cases of metastatic cardiac tumors. Medical, radiological and pathological data of identified cases was retrieved and reviewed. Results: Out of thousands of registered cardiac surgeries we found less than a dozen cases of metastatic cardiac tumors classified as melanoma, carcinomas of lung, colon and kidney and sarcomas of uterine origin. We found that metastatic cardiac tumors comprised 15.8% of all the cardiac tumors. Conclusions: Metastatic cardiac tumors are extremely rare. As new diagnostic technologies and improved survival of oncological patients may increase the incidence of metastatic cardiac tumors in the future, awareness to their existence and knowledge of their presentation are key factors in their timely recognition. © 2018 The Author(s). - Some of the metrics are blocked by yourconsent settings
Publication Metastatic cardiac tumors: From clinical presentation through diagnosis to treatment(2018) ;Burazor, Ivana (24767517700) ;Aviel-Ronen, Sarit (6602442666) ;Imazio, Massimo (55787131200) ;Goitein, Orly (6505772996) ;Perelman, Marina (57196546470) ;Shelestovich, Natalia (57196438363) ;Radovanovic, Ninoslav (57200860335) ;Kanjuh, Vladimir (57213201627) ;Barshack, Iris (7003939286)Adler, Yehuda (7005992564)Background: To evaluate the prevalence of metastatic tumors involving the myocardium and study their presentation in order to increase awareness to their existence. Methods: Pathological reports from Sheba Medical Center (Israel, January 1, 2010 through December 31, 2015) and medical records from The Institute for Cardiovascular Diseases of Vojvodina, Sremska Kamenica (Serbia, 23years period) were screened for cases of metastatic cardiac tumors. Medical, radiological and pathological data of identified cases was retrieved and reviewed. Results: Out of thousands of registered cardiac surgeries we found less than a dozen cases of metastatic cardiac tumors classified as melanoma, carcinomas of lung, colon and kidney and sarcomas of uterine origin. We found that metastatic cardiac tumors comprised 15.8% of all the cardiac tumors. Conclusions: Metastatic cardiac tumors are extremely rare. As new diagnostic technologies and improved survival of oncological patients may increase the incidence of metastatic cardiac tumors in the future, awareness to their existence and knowledge of their presentation are key factors in their timely recognition. © 2018 The Author(s). - Some of the metrics are blocked by yourconsent settings
Publication Psychometric validation of the short version of the Information Needs in Cardiac Rehabilitation scale through a first global assessment(2024) ;De Melo Ghisi, Gabriela Lima (59361815100) ;Da Cruz, Mayara Moura Alves (57214469562) ;Vanderlei, Luiz Carlos Marques (8766040800) ;Liu, Xia (57206738971) ;Xu, Zhimin (57705732200) ;Jiandani, Mariya Prakash (57201735672) ;Cuenza, Lucky (56502374800) ;Kouidi, Evangelia (56010483400) ;Giallauria, Francesco (6507763793) ;Mohammed, Jibril (56575677500) ;Maskhulia, Lela (14034191700) ;Trevizan, Patricia Fernandes (35118162300) ;Batalik, Ladislav (56491275900) ;Pereira, Danielle Gomes (55419327100) ;Tourkmani, Nidal (56603202500) ;Burazor, Ivana (24767517700) ;Venturini, Elio (13610066900) ;Lira, Gerlene Grudka (57210959002) ;Rehfeld, Manuella Bennaton Cardoso Vieira (59416789200) ;Neves, Victor Ribeiro (37097600500) ;Borges, Geovana de Jesus (59417446700) ;Kim, Won-Seok (57028735900) ;Cha, Seungwoo (57196322873) ;Zhang, Ling (56487248100)Grace, Sherry L. (7006091012)Aims: Tailored education is recommended for cardiac patients, yet little is known about information needs in areas of the world where it is most needed. This study aims to assess (i) the measurement properties of the Information Needs in Cardiac Rehabilitation short version (INCR-S) scale and (ii) patient's information needs globally. Methods and results: In this cross-sectional study, English, simplified Chinese, Portuguese, or Korean versions of the INCR-S were administered to in- or out-patients via Qualtrics (January 2022-November 2023). Members of the International Council of Cardiovascular Prevention and Rehabilitation community facilitated recruitment. Importance and knowledge sufficiency of 36 items were rated. Links to evidence-based lay education were provided where warranted. A total of 1601 patients from 19 middle- and high-income countries across the world participated. Structural validity was supported upon factor analysis, with five subscales extracted: symptom response/medication, heart diseases/diagnostic tests/treatments, exercise and return-to-life roles/programmes to support, risk factors, and healthy eating/psychosocial management. Cronbach's alpha was 0.97. Construct validity was supported through significantly higher knowledge sufficiency ratings for all items and information importance ratings for all subscales in cardiac rehabilitation (CR) enrolees vs. non-enrolees (all P < 0.001). All items were rated as very important - particularly regarding cardiac events, nutrition, exercise benefits, medications, symptom response, risk factor control, and CR - but more so in high-income countries in the Americas and Western Pacific. Knowledge sufficiency ranged from 30.0 to 67.4%, varying by region and income class. Ratings were highest for medications and lowest for support groups, resistance training, and alternative medicine. Conclusion: Identification of information needs using the valid and reliable INCR-S can inform educational approaches to optimize patients' health outcomes across the globe. © 2024 The Author(s). - Some of the metrics are blocked by yourconsent settings
Publication The effects of implementation of guideline-directed medical therapy on relief of angina in patients with stable coronary artery disease in Serbia(2016) ;Ilić, Ivan (57210906813) ;Stanković, Ivan (57197589922) ;Janićijević, Aleksandra (57188634595) ;Kušić, Jovana (56014110700) ;Vidaković, Radosav (13009037100) ;Otašević, Petar (55927970400) ;Andrić, Vesna (35168449100) ;Poznanović, Snežana (57193090177) ;Petrović, Ivana (35563660900) ;Burazor, Ivana (24767517700) ;Ristić, Arsen (7003835406) ;Ilić, Stevan (7004597967) ;Benc, Dragan (6508009888) ;Davidović, Goran (14008112400) ;Stojković, Gabrijela (51162152900) ;Putniković, Biljana (6602601858)Nešković, Aleksandar N. (35597744900)Introduction Adherence to proposed lifestyle changes and prescribed medication in patients with stable coronary artery disease (SCAD) is poor. Objective We sought to investigate the influence of adjusting guideline proposed medications on relief of angina in a large group of patients with SCAD in Serbia. Methods The study included a total of 3,490 patients from 15 cardiology clinics with symptoms of stable angina and at least one of the following criteria: abnormal electrocardiogram (ECG), history of myocardial infarction (MI), positive stress test, significant coronary artery disease on coronary angiogram or previous revascularization. All the patients underwent comprehensive evaluation at initial visit and after two months. The relief of angina was study end-point defined as any reduction in Canadian Cardiology Society (CCS) class, number of angina attacks per week and/or number of tablets of short-acting nitrates per week. Results Most patients were included based on abnormal ECG (48.4%). At Visit 1, the average number of prescribed classes of medications to a single patient increased from 4.16 ± 1.29 to 4.63 ± 1.57 (p < 0.001). At the follow-up, the patients had significantly lower blood pressure (141 ± 19/85 ± 11 vs. 130 ± 12/80 ± 8 mmHg; p < 0.001) and most of them reported CCS class I (63.3%). The average weekly number of angina attacks was reduced from 2.82 ± 2.50 at Visit 1 to 1.72 0 ± 1.66 at Visit 2, as well as average weekly use of short-acting nitrates to treat these attacks (2.69 ± 2.53 to 1.74 ± 1.47 tablets; p < 0.001 for all). Conclusion Adjustment of prescribed medications to guideline recommendations in a large Serbian patient population with prevalent risk factors led to significant relief of angina. ©2016, Serbia Medical Society. All rights reserved. - Some of the metrics are blocked by yourconsent settings
Publication Women's Cardiac Rehabilitation Barriers: Results of the International Council of Cardiovascular Prevention and Rehabilitation's First Global Assessment(2023) ;Ghisi, Gabriela Lima de Melo (36091244700) ;Kim, Won-Seok (57028735900) ;Cha, Seungwoo (57196322873) ;Aljehani, Raghdah (57431746600) ;Cruz, Mayara Moura Alves (57214469562) ;Vanderlei, Luiz Carlos Marques (8766040800) ;Pepera, Garyfallia (35318289900) ;Liu, Xia (57206738971) ;Xu, Zhimin (57705732200) ;Maskhulia, Lela (14034191700) ;Venturini, Elio (13610066900) ;Chuang, Hung-Jui (57158706100) ;Pereira, Danielle Gomes (55419327100) ;Trevizan, Patricia Fernandes (35118162300) ;Kouidi, Evangelia (56010483400) ;Batalik, Ladislav (56491275900) ;Ghanbari Firoozabadi, Mahdieh (56155327900) ;Burazor, Ivana (24767517700) ;Jiandani, Mariya Prakash (57201735672) ;Zhang, Ling (56487248100) ;Tourkmani, Nidal (56603202500)Grace, Sherry L. (7006091012)Background: Cardiac rehabilitation (CR) programs are underutilized globally, especially by women. In this study we investigated sex differences in CR barriers across all world regions, to our knowledge for the first time, the characteristics associated with greater barriers in women, and women's greatest barriers according to enrollment status. Methods: In this cross-sectional study, the English, Simplified Chinese, Arabic, Portuguese, or Korean versions of the Cardiac Rehabilitation Barriers Scale was administered to CR-indicated patients globally via Qualtrics from October 2021 to March 2023. Members of the International Council of Cardiovascular Prevention and Rehabilitation community facilitated participant recruitment. Mitigation strategies were provided and rated. Results: Participants were 2163 patients from 16 countries across all 6 World Health Organization regions; 916 (42.3%) were women. Women did not report significantly greater total barriers overall, but did in 2 regions (Americas, Western Pacific) and men in 1 (Eastern Mediterranean; all P < 0.001). Women's barriers were greatest in the Western Pacific (2.6 ± 0.4/5) and South East Asian (2.5 ± 0.9) regions (P < 0.001), with lack of CR awareness as the greatest barrier in both. Women who were unemployed reported significantly greater barriers than those not (P < 0.001). Among nonenrolled referred women, the greatest barriers were not knowing about CR, not being contacted by the program, cost, and finding exercise tiring or painful. Among enrolled women, the greatest barriers to session adherence were distance, transportation, and family responsibilities. Mitigation strategies were rated as very helpful (4.2 ± 0.7/5). Conclusions: CR barriers—men's and women's—vary significantly according to region, necessitating tailored approaches to mitigation. Efforts should be made to mitigate unemployed women's barriers in particular. © 2023 The Authors
